EquityZen Growth Technology Fund II LLC - Series 15
Raised
$5M
Investors
39
Min Invest
$50,000
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund II LLC - Series 15 is a Delaware-based pooled investment fund vehicle filed by EquityZen Advisors LLC and executive Phil Haslett on April 14, 2025. The filing reports $4.6M raised from 39 investors under Rule 506(b) and Section 3(c) exemptions, with a $50K minimum investment. This entity is part of the EquityZen platform, which operates over 150 related fund series focused on private equity and late-stage technology investments.
This private equity fund vehicle follows a typical 506(b) exemption pattern with a mid-tier $50K minimum investment, accessible to accredited investors through private placement. The $118K average investor commitment and 39-investor base align with established SPV and series fund structures common in the secondary private market segment.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Phil Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. AltStreet analysis (summaries, flags, category context) is generated by Claude from this primary source data and reviewed for accuracy. Platform-provided information (if present) is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. EDGAR data is verified read-only — platforms may request factual corrections for demonstrable inaccuracies by contacting research@altstreet.investments. This page does not constitute investment advice.
